TOP TIERMARKET NEWSWIRE
News & sentiment

MOONLAKE IMMUNOTHERA A (MLTX) — News & AI sentiment

MOONLAKE IMMUNOTHERA A (MLTX) news roundup. 4 stories aggregated over the last 30 days. Average 30-day sentiment is 55.5/100. Recent insider activity (SEC Form 4, 90-day window): 0 purchases totalling $0 and 10 sales totalling $9.6M — net selling of $9.6M. No congressional trade disclosures in the last 90 days. Data shown on this page is delayed 4 hours. Real-time access — including the live wire, real-time alerts, the live S&P 500 heatmap, and the AI Top Trades long/short board — is available with a Top Tier Newswire Pro subscription.

Public view, delayed 4h. For real-time news, alerts, AI sentiment and the long/short AI Top Trades board:Open in the live terminal →
24h stories
0
7d stories
0
30d stories
4
avg sentiment 55.5/100
Insider net (90d)
$9.6M
0 buys · 10 sells
Congress (90d)
0
0 buys · 0 sells

Latest stories on MLTX

H.C. Wainwright reiterates Moonlake stock buy rating on funding
Investing.com Analyst Ratings61 · neutralanalyst
Jul 20
Jul 13
MoonLake Immunotherapeutics' CFO Sells 39K Shares
The Motley Fool42 · neutralgeneral
Jul 3
Jun 30
Jun 26
Jun 25
Jun 24
Jun 24
Jun 24
Jun 24
Jun 23
Jun 22
Jun 22
Jun 22
Jun 22
Jun 22
Jun 22
Jun 22
Jun 22
Why Is MLTX Stock Rallying Nearly 20% Overnight?
Stocktwits News67 · bullishproduct/pr
Jun 22
Jun 21
Jun 21
Jun 17
Jun 9
Why Did MLTX Stock Rise After-Hours Today?
Stocktwits News56 · neutralproduct/pr
Jun 9
Open MLTX in the live Top Tier Newswire terminal for real-time stories, sentiment, insider + congress alerts, and the AI Top Trades long/short board.Start a 1-day free trial →